lhermitt
phenomenon
tingl
electricaltyp
sensat
experienc
result
neck
flexion
felt
due
mechanosensit
demyelin
axon
major
histocompat
complex
area
chromosom
encod
immun
respons
gene
possibl
area
genet
suscept
multipl
sclerosi
myelopathi
diseas
spinal
cord
typic
weak
andor
sensori
disturb
level
demyelin
plaqu
lesion
multipl
sclerosi
character
patholog
light
gray
pink
discolor
white
matter
region
central
nervou
system
relaps
neurolog
sign
symptom
occur
individu
multipl
sclerosi
persist
day
week
follow
partial
complet
recoveri
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
result
destruct
myelin
axon
caus
diseas
unknown
howev
believ
immunemedi
process
diseas
character
relaps
remiss
neurolog
sign
symptom
earli
cours
follow
case
progress
declin
neurolog
function
although
individu
year
age
time
diagnosi
diseas
affect
age
group
caus
vari
level
disabl
women
twice
like
develop
diseas
men
import
featur
multipl
sclerosi
mark
variabl
neurolog
symptom
clinic
cours
four
differ
type
diseas
cours
describ
patient
present
relapsingremit
diseas
individu
develop
neurolog
symptom
sign
hour
day
typic
recov
week
follow
variou
length
diseasefre
period
individu
relaps
residu
symptom
wherea
other
frequent
relaps
accumul
disabl
approxim
onehalf
patient
relapsingremit
diseas
go
develop
secondari
progress
diseas
case
featur
relapsingremit
diseas
follow
gradual
declin
function
without
superimpos
relaps
primari
progress
diseas
affect
individu
ms
character
gradual
declin
neurolog
condit
onset
without
relaps
form
diseas
progress
typic
seen
older
individu
often
male
progress
myelopathi
fourth
type
progressiverelaps
ms
similar
primari
progress
ms
superimpos
relaps
term
benign
ms
use
care
current
estim
diseas
truli
remain
benign
patient
base
epidemiolog
genet
data
ms
believ
caus
environment
agent
trigger
diseas
suscept
individu
trigger
unknown
like
infecti
advanc
biotechnolog
better
trial
design
led
new
therapi
least
partial
effect
treat
diseas
estim
individu
unit
state
ms
million
worldwid
preval
diseas
individu
northern
european
descent
wherea
asian
preval
per
highest
preval
rate
case
per
individu
orkney
island
north
scotland
hispan
asian
african
american
less
like
caucasian
diseas
ms
usual
sporad
often
document
famili
histori
howev
famili
shown
increas
frequenc
diseas
thu
attent
focus
genet
versu
environment
featur
diseas
preval
ms
vari
along
northsouth
gradient
worldwid
increas
one
move
away
equat
even
countri
rel
homogen
racial
popul
gradient
diseas
preval
suggest
environment
caus
except
pattern
sicili
malta
two
area
close
proxim
differ
preval
rate
addit
ethnic
group
appear
resist
diseas
highrisk
area
hutterit
western
canada
nativ
american
north
america
reinforc
genet
featur
diseas
furthermor
northsouth
gradient
may
explain
migrat
pattern
ethnic
group
tend
migrat
similar
climat
studi
individu
move
highrisk
lowrisk
area
puberti
show
individu
carri
risk
first
locat
develop
ms
suggest
environment
factor
may
trigger
diseas
earli
life
cluster
case
ms
describ
mani
withstood
scrutini
provid
evid
epidem
ms
occur
summari
data
indic
geograph
distribut
ms
due
singl
environment
factor
genet
factor
alon
explain
distribut
epidemiolog
studi
provid
earli
albeit
indirect
evid
genet
suscept
toward
develop
ms
studi
monozygot
twin
illustr
lifetim
risk
develop
diseas
one
sibl
effect
dizygot
twin
risk
similar
nontwin
sibl
higher
normal
popul
addit
studi
shown
risk
higher
full
sibl
rather
halfsibl
sibl
individu
ms
rais
separ
home
retain
higher
risk
develop
diseas
firstdegre
adopt
nonbiolog
rel
increas
risk
compar
gener
popul
thu
genet
rather
environment
factor
like
explain
famili
cluster
diseas
earli
associ
risk
develop
ms
major
histocompat
complex
mhc
chromosom
encod
immun
respons
gene
recogn
mhc
class
class
ii
molecul
glycoprotein
locat
cell
surfac
present
antigen
antigenspecif
cell
individu
abil
react
antigen
determin
mhc
region
cell
interact
mhc
class
molecul
surfac
nucleat
cell
human
molecul
known
human
leukocyt
antigen
hla
b
c
class
ii
molecul
present
cell
includ
monocyt
macrophag
endotheli
cell
microgli
cell
antigen
describ
hladp
dq
anddr
although
may
weak
associ
multipl
studi
shown
increas
occurr
haplotyp
associ
ms
individu
ms
hladr
haplotyp
thu
essenti
suffici
caus
diseas
also
possibl
unidentifi
gene
close
hla
gene
suscept
locu
recent
genet
studi
indic
multipl
unlink
gene
may
influenc
risk
develop
ms
gene
may
add
risk
differ
gene
may
influenc
suscept
individu
other
screen
entir
genom
region
relat
risk
ms
anonym
genet
marker
identifi
suscept
loci
mhc
region
one
model
ms
anim
experiment
allerg
encephalomyel
eae
anim
model
suscept
develop
demyelin
base
genet
risk
specif
chromosom
segment
identifi
anim
model
increas
risk
model
suggest
initi
event
occur
diseas
may
mediat
differ
genet
factor
caus
later
progress
diseas
search
infecti
caus
ms
pursu
mani
year
bacteria
spirochet
atyp
bacteria
consid
although
confirm
virus
focu
search
base
epidemiolog
genet
patholog
serolog
studi
nonrandom
northsouth
gradient
diseas
occurr
describ
previous
atyp
autoimmun
diseas
suggest
role
environment
trigger
low
rate
concord
monozygot
twin
evid
ms
pure
genet
diseas
twin
share
mani
childhood
diseas
one
would
expect
concord
rate
much
higher
ms
result
nonspecif
respons
multipl
agent
like
specif
poorli
transmiss
agent
lead
activ
diseas
patholog
studi
show
chang
seen
central
nervou
system
similar
ms
viral
ill
produc
inflammatori
demyelin
lesion
brain
persist
viral
infect
caus
chronic
demyelin
immunolog
studi
note
cerebrospin
fluid
similar
viral
infect
ms
viral
infect
howev
oligoclon
band
identifi
due
specif
viral
antigen
ms
oligoclon
band
known
react
specif
antigen
antibodi
elev
cerebrospin
fluid
serum
patient
ms
virus
measl
epsteinbarr
viru
rubella
mump
herp
simplex
like
due
nonspecif
increas
due
genet
immunolog
factor
rather
specif
respons
viru
anim
model
viral
demyelin
diseas
resembl
ms
includ
canin
distemp
viru
theiler
murin
encephalomyel
murin
coronaviru
visna
furthermor
virus
known
result
demyelin
diseas
human
exampl
postinfecti
encephalomyel
acut
dissemin
encephalomyel
adem
occur
follow
infect
measl
varicella
epsteinbarr
viru
persist
infect
papovaviru
caus
progress
multifoc
leukoencephalopathi
pml
immunocompromis
individu
propos
explain
virus
may
caus
ms
includ
immun
system
respons
chronic
transient
viru
reactiv
persist
infect
viral
infect
immunocompet
cell
includ
lymphocyt
molecular
mimicri
may
explain
immun
system
respons
viru
infecti
agent
model
suggest
viral
peptid
similar
compon
myelin
immun
system
recogn
foreign
viral
peptid
crossreact
myelin
result
activ
immun
system
damag
result
exposur
addit
myelin
antigen
exposur
antigen
may
result
epitop
shift
initi
incit
antigen
longer
remain
sole
perpetr
immun
process
virus
eg
epsteinbarr
viru
cytomegaloviru
measl
known
peptid
similar
antigen
identifi
myelin
compon
furthermor
antigen
may
compon
myelin
enzym
regulatori
protein
may
affect
immun
function
way
eg
permeabl
bloodbrain
barrier
myelin
metabol
superantigen
bacteri
viral
envelop
compon
activ
larg
popul
cell
multipl
clone
cell
may
anoth
mechan
clone
auto
reactiv
cell
may
activ
other
argu
latent
viral
infect
result
diseas
period
relaps
would
explain
reactiv
viru
progress
may
due
failur
host
inactiv
virus
sever
virus
known
exist
human
central
nervou
system
reactiv
exampl
herp
zoster
caus
chicken
pox
childhood
reactiv
adult
shingl
diseas
rash
dermatom
pattern
case
viru
remain
persist
infect
measl
viru
caus
subacut
scleros
panenceph
hiv
infect
result
variou
neurolog
complic
includ
dementia
caus
progress
myelopathi
whether
viru
caus
direct
injuri
neural
tissu
caus
bystand
inflamm
demyelin
unknown
final
possibl
viral
infect
lymphocyt
immun
cell
lead
chang
function
cell
ultim
alter
immun
mani
virus
suggest
incit
agent
ms
recent
interest
human
herpesviru
type
herp
latent
nervou
system
transport
within
axon
known
caus
demyelin
caus
roseola
sixth
diseas
children
like
herpesvirus
may
reactiv
adult
nervou
system
presenc
viru
confirm
brain
individu
ms
other
determin
role
viru
ms
requir
addit
test
author
believ
inflammatori
demyelin
diseas
process
immunemedi
even
though
caus
remain
unknown
target
inflamm
may
compon
myelin
process
like
begin
cell
antimyelin
cell
recogn
normal
adult
peripher
blood
ms
cell
migrat
central
nervou
system
humer
immun
respons
also
like
base
intrathec
presenc
immunoglobulin
antigen
recogn
antibodi
determin
myelin
basic
protein
mbp
proteolipid
protein
make
myelin
protein
myelin
oligodendroglia
protein
mog
make
central
nervou
system
myelin
protein
present
peripher
nervou
system
may
antigen
exclus
central
nervou
system
diseas
mog
locat
oligodendroglia
surfac
outer
lamella
myelin
sheath
thu
access
attack
possibl
target
includ
myelinassoci
glycoprotein
ab
crystallin
nucleotid
phosphodiesteras
viral
antigen
marmoset
model
relaps
experiment
allerg
encephalomyel
histolog
similar
ms
demonstr
cell
recogn
mbp
mog
cell
induc
inflamm
demyelin
occur
unless
mog
antibodi
present
although
mog
may
initi
antigen
incit
factor
exposur
result
inflamm
induc
new
antigen
epitop
shift
antigen
diseas
difficult
identifi
possibl
multipl
antigen
figur
illustr
propos
mechan
immunemedi
injuri
ms
genet
environment
factor
virus
bacteria
superantigen
caus
activ
circul
cell
adhes
molecul
circul
cell
surfac
late
antigen
lymphocyt
function
associ
antigen
bind
complementari
receptor
endothelium
intracellular
cell
adhes
vascular
cell
adhes
central
nervou
system
activ
cell
secret
cytokin
includ
tumor
necrosi
factorb
tnfb
interferong
ifng
turn
activ
antigen
present
cell
apc
includ
astrocyt
macrophag
microglia
class
ii
mch
molecul
apc
cell
interact
presenc
central
nervou
system
antigen
costimul
molecul
apc
lymphocyt
necessari
activ
cell
cell
differenti
proinflammatori
cell
antiinflammatori
cell
proinflammatori
cell
secret
cytokin
tnfa
b
ifng
result
activ
variou
process
caus
injuri
myelin
oligodendrocyt
antibodymedi
injuri
may
cell
depend
occur
via
complement
activ
cellmedi
injuri
induc
damag
releas
proinflammatori
cytokin
bind
fasligand
fa
bind
ab
crystallin
result
apoptosi
program
cell
death
macrophag
induc
myelin
injuri
phagocytosi
secret
toxic
substanc
proteas
nitric
oxid
oxygen
radic
proinflammatori
cytokin
apoptosi
may
occur
via
fasligand
interact
case
cytotox
autoreact
cell
may
primari
caus
injuri
bind
class
mhc
antigen
oligodendrocyt
may
also
bind
via
fa
induc
apoptosi
addit
cell
may
releas
perforin
creat
membran
pore
kill
cell
final
factor
may
lead
injuri
oligodendroglia
result
die
back
oligodendrogliopathi
result
vari
degre
demyelin
axon
destruct
even
area
damag
other
variou
stage
repair
antiinflammatori
process
activ
via
cell
secret
cytokin
decreas
inflamm
downregul
immun
respons
process
occur
simultan
inflammatori
respons
thinli
myelin
axon
patholog
specimen
indic
remyelin
occur
patient
ms
repair
like
begin
resolut
inflamm
edema
new
sodium
channel
may
develop
demyelin
axon
allow
propag
activ
potenti
known
sodium
channel
develop
neuron
surround
glial
cell
oligodendroglia
progenitor
capabl
prolifer
identifi
specif
role
cell
clear
known
remyelin
occur
inflamm
control
final
result
inflammatori
process
irrevers
axon
injuri
known
occur
earli
diseas
find
suggest
earli
intervent
diseas
cours
prevent
decreas
inflamm
may
prevent
axon
injuri
allow
remyelin
multipl
potenti
site
therapeut
intervent
consid
includ
blockag
adhes
co
stimul
molecul
cytokin
therapi
modul
cell
via
vaccin
patholog
section
brain
individu
ms
reveal
welldemarc
lesion
plaqu
appear
pink
gray
microscop
lesion
character
inflamm
demyelin
gliosi
inflammatori
lesion
perivascular
leptomening
infiltr
lymphocyt
monocyt
macrophag
histopatholog
studi
show
macrophag
cell
promin
cell
type
within
lesion
fewer
b
cell
plasma
cell
lesion
character
activ
acut
chronic
activ
chronic
inact
acut
lesion
perivascular
parenchym
infiltr
mononuclear
cell
cell
macrophag
exist
cell
mostli
larg
round
lipidladen
macrophag
variabl
number
cell
present
mhc
class
ii
posit
cell
abund
similar
find
seen
adem
anim
model
cellmedi
immun
respons
case
demyelin
occur
mstype
plaqu
present
impli
must
anoth
factor
present
demyelin
occur
chronic
activ
plaqu
mhc
class
ii
cell
lipidladen
macrophag
border
lesion
central
chronic
inact
lesion
mhc
class
iiposit
cell
hypocellular
recent
evid
indic
patholog
process
may
vari
individu
lucchinetti
lassmann
describ
differ
type
patholog
appear
base
immunohistochem
studi
first
type
show
area
demyelin
oligodendroglia
loss
local
deposit
demyelin
antibodi
complement
activ
preserv
oligodendroglia
cell
favor
remyelin
recoveri
second
type
demyelin
howev
destruct
loss
oligodendroglia
cell
presenc
cell
macrophag
area
local
precipit
antibodi
complement
evid
third
type
involv
primari
demyelin
gradient
loss
oligodendroglia
cell
toward
center
inact
plaqu
inact
plaqu
profound
oligodendroglia
loss
fourth
type
describ
primari
oligodendroglia
destruct
white
matter
near
plaqu
result
secondari
demyelin
fifth
type
describ
demyelin
profound
loss
axon
oligodendrocyt
astrocyt
like
due
differ
stage
diseas
sinc
individu
tend
similar
pattern
patholog
chang
throughout
brain
rather
type
injuri
may
result
differ
immunolog
mechan
occur
patient
within
patient
irrevers
disabl
ms
attribut
axon
injuri
evid
autopsi
specimen
charcot
recogn
degener
axon
ms
earli
recent
axon
transect
demonstr
even
earli
stage
diseas
find
suggest
accumul
axon
injuri
earli
may
result
progress
disabl
attempt
prevent
axon
damag
may
prevent
longterm
disabl
myelin
act
electr
insul
brain
spinal
cord
lipid
sheath
produc
oligodendrocyt
brain
spinal
cord
one
oligodendrocyt
insul
axon
myelin
produc
layer
lamella
interrupt
node
ranvier
node
ranvier
high
densiti
sodium
channel
respons
sodium
ion
shift
depolar
area
allow
product
propag
action
potenti
conduct
saltatori
continu
process
internod
area
area
node
ranvier
myelin
sheath
low
proport
sodium
channel
high
proport
potassium
channel
especi
perinod
region
potassium
channel
oppos
depolar
depolar
produc
electr
charg
conduct
myelin
segment
next
node
depolar
myelin
increas
speed
conduct
effici
demyelin
slow
action
potenti
conduct
block
occur
conduct
block
prevent
propag
axon
action
potenti
sodium
channel
develop
along
demyelin
internod
area
way
allow
propag
action
potenti
although
slower
reorgan
demyelin
axon
result
higher
normal
densiti
sodium
demyelin
region
factor
may
interfer
conduct
circul
immun
factor
edema
addit
reorgan
sodium
channel
resolut
edema
clearanc
factor
may
restor
conduct
synapt
chang
conduct
normal
unmyelin
axon
may
also
restor
function
known
small
chang
temperatur
electrolyt
produc
conduct
block
demyelin
axon
patient
symptom
may
recur
elev
bodi
temperatur
result
ill
increas
environment
temperatur
uthoff
phenomenon
one
best
known
phenomena
elev
bodi
temperatur
exercis
individu
develop
decreas
visual
acuiti
eye
previous
affect
optic
neuriti
symptom
resolv
bodi
temperatur
return
normal
train
impuls
also
block
propag
action
potenti
prolong
refractori
periodfth
time
neuron
depolar
clinic
occur
patient
complain
fatig
muscl
strength
repetit
use
extrem
occur
walk
possibl
modif
sodium
potassium
channel
demyelin
neuron
may
result
improv
clinic
potassium
channel
blocker
drug
improv
symptom
patient
ms
especi
heat
sensit
current
feder
drug
administr
fda
approv
drug
research
modif
sodium
potassium
channel
may
lead
therapi
provid
improv
conduct
demyelin
axon
paroxysm
symptom
ms
uniqu
featur
diseas
basi
physiolog
demyelin
axon
symptom
includ
episod
recurr
hemibodi
sensori
symptom
paroxysm
dysarthria
paroxysm
pain
trigemin
neuralgia
phenomena
may
result
ephapt
transmiss
occur
adjac
demyelin
axon
commun
later
fashion
result
recurr
abnorm
stimuli
lhermitt
phenomena
transient
electr
shocklik
sensat
spine
andor
extrem
believ
due
increas
mechanosensit
demyelin
axon
spinal
cord
result
neck
flexion
caus
mechan
chang
spinal
cord
clinic
featur
ms
base
locat
lesion
rather
sever
lesion
lesion
must
occur
eloqu
area
produc
symptom
mani
lesion
occur
area
clinic
recogn
symptomat
includ
periventricular
white
matter
lesion
identifi
near
later
ventricl
relaps
ms
defin
exacerb
clinic
worsen
neurolog
sign
symptom
persist
week
month
follow
period
remiss
symptom
must
present
least
hr
consid
relaps
gener
present
longer
common
sensori
symptom
often
earliest
symptom
occasion
peculiar
distribut
addit
sensori
symptom
may
object
find
thu
ascrib
caus
stress
patient
often
complain
numb
often
experienc
posit
sensori
phenomena
tingl
dysesthesia
abil
detect
vibrat
extrem
often
decreas
identifi
neurolog
examin
earli
diseas
often
sensori
symptom
ms
due
lesion
posterior
column
rather
spinothalam
tract
howev
decreas
pinprick
temperatur
sensat
occur
lhermitt
phenomenon
sensori
symptom
patient
experi
sudden
brief
electr
sensat
along
spine
extrem
less
commonli
radicular
pattern
pain
may
occur
like
due
demyelin
sensori
root
entri
zone
lancin
neuralgia
dysesthesia
uncommon
useless
hand
develop
sensori
disrupt
sensori
spinal
tract
affect
vibrat
twopoint
discrimin
propriocept
often
occur
result
high
cervic
spinal
cord
lesion
posterior
column
medial
lemniscu
system
brain
stem
although
strength
preserv
hand
difficult
manipul
task
sensori
disrupt
may
occur
spinal
disord
occur
young
individu
like
due
ms
disord
visual
system
common
onset
ms
optic
neuriti
result
acut
subacut
monocular
loss
vision
patient
complain
blur
vision
dim
vision
often
associ
photophobia
pain
increas
eye
movement
examin
often
disclos
decreas
visual
acuiti
central
scotoma
visual
loss
optic
nerv
head
may
appear
swollen
hemorrhag
exud
papil
may
normal
appear
retrobulbar
neuriti
funduscop
examin
color
vision
often
affect
easili
test
ask
patient
view
red
object
eye
separ
compar
differ
appear
affer
pupillari
defect
elicit
shine
bright
light
pupil
may
demonstr
delay
pupillari
respons
dilat
light
brought
affect
eye
often
visual
acuiti
return
normal
within
sever
week
later
optic
atrophi
may
detect
pale
optic
nerv
head
evid
funduscop
examin
type
visual
field
defect
describ
includ
bilater
homonym
hemianopia
quadrantanopia
indic
lesion
posterior
visual
system
although
optic
neuriti
commonli
associ
ms
condit
includ
system
lupu
erythematosu
sarcoidosi
must
consid
extraocular
movement
disord
also
rel
common
examin
often
show
horizont
nystagmu
asymptomat
rotari
upbeat
downbeat
nystagmu
also
describ
bilater
internuclear
ophthalmoplegia
ino
result
lesion
brain
stem
medial
longitudin
fasciculu
patient
develop
failur
ipsilater
eye
adduct
wherea
contralater
eye
develop
abduct
nystagmu
patient
may
asymptomat
central
gaze
horizont
gaze
develop
diplopia
oscillopsia
sens
movement
imag
ino
may
bilater
unilater
incomplet
ino
frequent
detect
slow
adduct
mild
abduct
nystagmu
skew
deviat
occur
one
eye
slightli
elev
compar
sixth
nerv
palsi
result
horizont
diplopia
occur
although
third
fourth
cranial
neuropathi
rare
vertigo
may
occur
demyelin
lesion
brain
stem
often
difficult
determin
vertigo
due
peripher
central
disord
featur
brain
stem
injuri
may
help
defin
caus
vertigo
necessari
conclud
vertigo
result
ms
although
infrequ
hear
loss
known
occur
dysfunct
facial
nerv
develop
lesion
seventh
nerv
brain
stem
subcort
lesion
caus
central
upper
motor
neuron
type
weak
confin
lower
aspect
face
myokymia
involuntari
wavelik
fascicul
movement
face
also
result
demyelin
speech
abnorm
includ
scan
dysarthria
word
syllabl
given
equal
emphasi
type
dysarthria
includ
pseudobulbar
nasal
speech
less
common
symptom
due
cortic
dysfunct
aphasia
agnosia
typic
ms
seizur
rare
tend
occur
later
diseas
cerebellar
find
common
earli
diseas
progress
ataxia
dysmetria
intent
tremor
dysdiadochokinesia
may
occur
cognit
dysfunct
estim
occur
patient
evid
neuropsycholog
dysfunct
aspect
diseas
mild
extrem
sever
profound
dementia
common
featur
cognit
dysfunct
includ
difficulti
recent
memori
sustain
attent
verbal
fluenci
conceptu
reason
visualspati
percept
determin
neuropsycholog
test
difficulti
easili
defin
simpl
procedur
clinic
miniment
statu
examin
sever
physic
diseas
correl
well
cognit
dysfunct
cognit
difficulti
significantli
disabl
secondari
fatigu
like
caus
patient
discontinu
work
depress
common
may
interfer
cognit
function
euphoria
present
associ
signific
cognit
difficulti
subcort
forebrain
lesion
bladder
dysfunct
although
unusu
onset
common
progress
diseas
symptom
includ
frequenc
urgenc
incontin
symptom
result
failur
store
failur
empti
bladder
failur
store
bladder
wall
sensit
expel
small
amount
urin
unexpectedli
due
bladder
wall
contract
failur
store
detrusor
muscl
weak
urin
difficult
expel
incontin
occur
overflow
full
bladder
often
patient
combin
problem
refer
detrusor
dyssynergia
bladder
wall
contract
occur
simultan
closur
extern
urethr
sphincter
prevent
empti
bladder
longterm
retent
vesicular
ureter
reflux
may
occur
along
hydronephrosi
renal
failur
bowel
dysfunct
includ
constip
bowel
urgenc
incontin
attempt
control
bladder
symptom
mani
patient
decreas
fluid
intak
worsen
constip
sexual
dysfunct
common
like
result
physiolog
psychosoci
factor
male
sexual
dysfunct
studi
extens
includ
erectil
dysfunct
decreas
sensat
decreas
libido
result
inabl
erect
ejacul
femal
patient
experi
decreas
sensat
decreas
absent
orgasm
decreas
arous
vagin
dryness
one
earli
manifest
ms
may
transvers
myeliti
patient
develop
acut
subacut
motor
sensori
symptom
lower
extrem
extend
thorax
defin
sensori
level
transvers
myeliti
may
repres
first
episod
ms
remain
monosymptomat
ill
similar
optic
neuriti
para
hemi
quadriplegia
may
develop
exacerb
progress
diseas
patient
develop
myelopathi
progress
weak
lower
extrem
later
involv
upper
extrem
associ
weak
increas
muscl
stretch
reflex
spastic
patient
experi
stiff
cramp
intermitt
spasm
discomfort
pain
may
result
final
paroxysm
symptomsfth
stereotyp
repetit
symptom
sign
occur
cluster
uniqu
featur
ms
patient
may
develop
tonic
seizur
dyston
postur
hand
arm
last
second
minut
individu
unabl
control
involuntari
flexion
stiff
paroxysm
symptom
includ
transient
dysarthria
sensori
phenomena
one
common
paroxysm
symptom
trigemin
neuralgia
patient
experi
sever
lancin
pain
face
repetit
basi
trigemin
neuralgia
may
occur
individu
without
ms
tend
occur
younger
age
frequent
bilater
individu
ms
diagnosi
ms
base
clinic
featur
ill
one
definit
test
ms
sign
symptom
defin
lesion
develop
time
least
month
apart
space
differ
area
central
nervou
system
symptom
tend
develop
sever
day
persist
sever
week
month
improv
mani
case
return
normal
neurolog
examin
gener
provid
object
evid
patient
symptom
howev
sensori
symptom
may
entir
subject
paraclin
data
includ
magnet
reson
imag
mri
cerebrospin
fluid
csf
evok
potenti
ep
use
confirm
disput
clinic
diagnosi
recent
criteria
develop
intern
panel
expert
field
ms
tabl
criteria
incorpor
mri
tool
assess
subclin
diseas
activ
provid
diagnosi
second
clinic
event
criteria
includ
visual
evok
potenti
form
evok
potenti
support
diagnosi
ms
although
unusu
paraclin
data
normal
patient
clinic
diagnosi
ms
csf
evalu
diagnost
research
standpoint
typic
csf
find
patient
ms
includ
less
white
blood
cell
per
cubic
millilit
cell
mostli
lymphocyt
occasion
macrophag
total
protein
glucos
level
usual
normal
howev
protein
level
may
slightli
elev
rare
mgdl
abnorm
csf
primarili
immunoglobulin
product
oligoclon
band
band
repres
multipl
monoclon
globulin
mostli
immunoglobul
igg
type
band
determin
agaros
electrophoresi
isoelectr
focus
indic
two
igg
band
gamma
region
agaros
electrophoresi
less
sensit
current
commonli
perform
band
present
persist
indefinit
low
falseposit
rate
approxim
presenc
band
may
predictor
chanc
develop
clinic
definit
ms
individu
monosymptomat
diseas
patient
band
csf
like
confirm
diagnosi
clinic
definit
ms
measur
csf
igg
product
includ
igg
synthesi
rate
igg
index
base
comparison
albumin
immunoglobulin
product
csf
serum
measur
consid
less
specif
sensit
oligoclon
band
use
indic
immun
abnorm
confirm
clinic
diagnosi
csf
difficult
obtain
marker
diseas
activ
pursu
urin
easili
access
fluid
although
volum
collect
time
infect
may
influenc
result
myelin
basic
proteinlik
mbpl
smaller
mbp
found
csf
cryptic
epitop
expos
central
nervou
system
myelinfposs
small
peptid
mbpl
fluctuat
independ
acut
relaps
howev
sustain
increas
present
patient
secondari
progress
ms
level
also
elev
individu
relapsingremit
ms
went
develop
secondari
progress
ms
current
marker
blood
use
diagnosi
ms
marker
consid
includ
circul
adhes
molecul
antibodi
cell
subpopul
cytokin
cytokin
receptor
evok
potenti
frequent
use
diagnosi
ms
prior
advent
mri
data
gener
present
repeat
stimuli
record
wave
form
ep
scalp
surfac
electrod
altern
checkerboard
pattern
use
visual
stimuli
visual
ep
repeat
auditori
click
use
brain
stem
auditori
ep
repeat
electr
sensori
stimul
use
tibial
somatosensori
ep
result
repeat
stimul
ep
defin
latenc
amplitud
base
standard
establish
laboratori
prolong
latenc
respons
suggest
demyelin
occur
loss
amplitud
respons
abnorm
necessarili
due
demyelin
studi
nonspecif
help
confirm
suspici
clinic
find
exampl
distant
histori
unusu
symptom
suggest
optic
neuriti
may
confirm
prolong
visual
evok
respons
record
stimul
one
eye
confirm
clinic
find
need
assess
ep
sinc
addit
inform
gather
current
ep
use
defin
prognosi
surrog
marker
diseas
activ
clinic
trial
magnet
reson
imag
first
use
studi
patient
ms
techniqu
rapidli
accept
clinic
realm
imag
gener
result
energi
releas
proton
posit
charg
hydrogen
nuclei
align
axi
strong
magnet
water
lipid
molecul
contain
hydrogen
atom
spin
precess
around
main
axi
axi
refer
magnet
vector
radio
frequenc
puls
caus
proton
rotat
spin
away
main
axi
radio
frequenc
puls
remov
signal
induc
proton
return
origin
rotat
signal
decay
time
refer
longitudin
decay
transvers
relax
time
time
result
environ
protein
exist
eg
csf
proton
requir
longer
time
return
equilibrium
radio
frequenc
puls
given
differ
time
differ
length
time
gener
differ
type
imag
weight
toward
weight
base
repetit
time
tr
time
puls
echo
time
te
time
gener
echo
imag
short
te
tr
wherea
imag
long
te
tr
csf
white
imag
demyelin
lesion
ms
fig
imag
chronic
lesion
appear
dark
area
black
hole
indic
tissu
destruct
probabl
axon
loss
newer
techniqu
fluidattenu
invers
recoveri
imag
cancel
signal
csf
result
demyelin
periventricular
lesion
easili
detect
fig
gadolinium
rare
element
paramagnet
substanc
given
intraven
provid
contrast
enhanc
area
breakdown
bloodbrain
barrier
gadolinium
shorten
relax
time
imag
appear
bright
bloodbrain
barrier
disrupt
enhanc
earliest
standard
mri
evid
newli
develop
ms
lesion
indic
acut
inflamm
often
persist
week
area
demyelin
gener
lesion
ms
ovoid
round
locat
adjac
bodi
tempor
horn
ventricl
corpu
callosum
infratentori
corticalsubcort
area
size
rang
millimet
larger
confluent
area
lesion
chang
size
time
may
disappear
howev
often
abnorm
persist
imag
white
matter
may
appear
diffus
abnorm
ie
dirti
white
matter
cortic
lesion
present
patholog
difficult
detect
mri
new
lesion
enlarg
old
lesion
occur
lesion
shrink
spinal
cord
lesion
detect
often
cervic
region
spinal
cord
may
appear
swollen
acut
phase
may
enhanc
use
gadolinium
optic
nerv
abnorm
visual
special
techniqu
suppress
signal
orbit
fat
frequenc
nonspecif
white
matter
chang
mri
variou
criteria
suggest
defin
brain
mri
abnorm
consist
clinic
diagnosi
ms
one
frequent
use
set
criteria
defin
signific
find
three
lesion
equal
greater
mm
least
one
locat
periventricular
infratentori
area
least
patient
clinic
definit
ms
mri
abnorm
explan
white
matter
abnorm
exist
includ
patchi
white
matter
abnorm
relat
hypertens
diabet
mellitu
lacunar
lesion
due
stroke
appear
isointens
csf
complet
tissu
destruct
typic
ms
lesion
individu
risk
cerebrovascular
diseas
may
incident
lesion
scatter
deep
white
matter
lesion
seen
system
lupu
erythematosu
also
locat
deep
white
matter
typic
periventricular
neurosarcoidosi
may
caus
white
matter
abnorm
frequent
associ
mening
enhanc
due
leptomening
adem
may
appear
ident
ms
lesion
tend
resolv
recur
glioma
may
appear
solitari
lesion
may
pseudotumor
lesion
ms
followup
mri
may
definit
although
biopsi
may
necessari
distinguish
two
final
inherit
disord
myelin
leukodystrophi
demonstr
symmetr
confluent
rather
patchi
discret
lesion
clinic
histori
examin
help
provid
altern
explan
abnorm
mri
provid
much
inform
underli
pathophysiolog
ms
serial
imag
demonstr
white
matter
lesion
present
even
individu
clinic
awar
diseas
activ
consist
process
vari
month
month
howev
frequenc
subclin
lesion
may
time
greater
clinic
diseas
clinic
evid
lesion
tend
present
brain
stem
spinal
cord
subclin
lesion
cerebrum
tend
increas
clinic
event
extent
lesion
present
scan
correl
well
clinic
examin
possibl
correl
cognit
dysfunct
howev
increas
extent
lesion
time
correl
increas
physic
disabl
number
area
contrastenhanc
lesion
correl
disabl
primari
progress
ms
often
lesion
present
imag
compar
relapsingremit
secondari
progress
ms
multipl
new
enhanc
lesion
tend
develop
time
may
indic
pathophysiolog
differ
diseas
type
mri
also
predict
valu
diagnosi
ms
individu
monosymptomat
diseas
transvers
myeliti
optic
neuriti
risk
eventu
diagnosi
clinic
definit
ms
higher
individu
abnorm
brain
mri
mri
use
tool
clinic
trial
realm
allow
shorter
clinic
trial
surrog
marker
diseas
activ
becom
increasingli
import
partial
effect
therapi
avail
need
incorpor
clinic
trial
new
agent
thu
requir
patient
order
prove
efficaci
problemat
use
mri
clinic
trial
show
effect
clinic
mri
aspect
vice
versa
appar
mismatch
data
need
clarifi
newer
techniqu
add
understand
imag
may
correl
well
clinic
disabl
magnet
transfer
imag
mti
reli
differ
relax
time
proton
bound
macromolecul
versu
proton
freeli
move
water
normal
appear
white
matter
weight
scan
abnorm
assess
mti
impli
diffus
process
demonstr
convent
imag
magnet
reson
spectroscopi
mr
use
mri
gener
spectra
hydrogen
high
energi
phosphoruscontain
metabolit
spectra
use
defin
patholog
lesion
includ
tumor
demyelin
spectra
reveal
major
reson
cholin
creatin
phosphocreatin
nacetylaspart
naa
cholin
present
membran
also
present
increas
myelin
breakdown
product
creatin
phosphocreatin
tend
stabl
ms
acut
lesion
naa
present
neuron
neuron
process
use
specif
axon
marker
white
matter
decreas
naa
indic
axon
patholog
mr
shown
decreas
naa
concentr
throughout
brain
individu
ms
impli
diffus
injuri
beyond
site
lesion
detect
routin
imag
techniqu
brain
atrophi
document
mri
show
volum
loss
around
third
later
ventricl
decreas
corpu
callosum
area
brain
width
atrophi
document
earli
cours
diseas
signific
clinic
disabl
like
anoth
indic
underli
axon
damag
thu
standard
newer
mri
techniqu
shown
ms
subclin
process
result
increas
mri
burden
diseas
find
also
support
hypothesi
axon
injuri
occur
earli
cours
diseas
may
diffus
previous
thought
prototyp
ms
one
spectrum
inflammatori
demyelin
diseas
includ
acut
ms
marburg
variant
balo
concentr
sclerosi
neuromyel
optica
devic
diseas
adem
acut
ms
present
fulmin
diseas
caus
sever
disabl
shortli
onset
often
death
within
year
lesion
destruct
typic
ms
axon
destruct
neurosi
age
lesion
mix
suggest
diseas
present
prior
clinic
diagnosi
balo
concentr
sclerosi
anoth
acut
ill
band
demyelin
altern
preserv
myelin
area
cerebellum
brain
stem
optic
chiasm
spinal
cord
often
spare
devic
diseas
neuromyel
optica
defin
optic
neuriti
myelopathi
occur
togeth
within
short
period
time
patholog
necrosi
evid
optic
nerv
spinal
cord
probabl
result
ischemia
swollen
tissu
adem
polysymptomat
diseas
occur
upper
respiratori
infect
viral
infect
follow
immun
diseas
occur
commonli
children
adult
includ
demyelin
multipl
area
includ
brain
stem
spinal
cord
optic
nerv
cerebrum
cerebellum
patient
may
associ
febril
ill
becom
comatos
rare
case
percentag
patient
ultim
diagnosi
ms
low
ie
initi
present
especi
fulmin
confus
first
event
ms
patholog
infiltr
mononuclear
cell
limit
periventricular
demyelin
ill
present
relapsingremit
type
ill
includ
behcet
diseas
character
oral
genit
ulcer
iridocycl
meningoenceph
thrombophleb
lyme
diseas
typic
radicular
peripher
nerv
involv
mistaken
ms
relapsingremit
cours
occasion
appear
mri
sjogren
syndrom
individu
vascul
skin
peripher
nervou
system
associ
dri
eye
dri
mouth
also
confus
ms
part
mri
abnorm
may
mimic
ms
neurosarcoidosi
may
relapsingremit
type
ill
gener
multipl
cranial
mononeuropathi
mri
show
leptomening
enhanc
associ
intracrani
diseas
cerebrovascular
diseas
may
confus
ms
especi
interpret
mri
scan
primari
central
nervou
system
vascul
system
lupu
erythematosu
sle
may
mimic
diseas
relapsingremittingtyp
ill
white
matter
lesion
present
mri
lesion
seen
sle
tend
subcort
periventricular
vitamin
b
defici
remain
differenti
ms
howev
tend
progressivetyp
diseas
symmetr
find
consist
myelopathi
peripher
neuropathi
myasthenia
gravi
may
fluctuat
sever
could
confus
ms
especi
present
diplopia
bulbar
featur
uncommon
earli
ms
lack
upper
motor
neuron
find
help
distinguish
ill
hereditari
dysmyelin
disord
usual
confus
ms
although
adult
onset
progress
myelopathi
one
must
consid
ill
adrenolmyeloneuropathi
much
written
natur
histori
ms
effect
therapi
alter
natur
histori
diseas
inform
invalu
mani
patient
expect
progress
diseas
told
diagnosi
ms
realiti
patient
walk
without
assist
year
diagnosi
mention
previous
major
patient
present
relapsingremit
diseas
approxim
onehalf
relapsingremit
patient
experi
progress
mani
featur
assess
prognost
marker
futur
outcom
includ
extent
disabl
year
age
sex
extent
initi
symptom
complet
partial
remiss
type
symptom
onset
eg
optic
neuriti
sensori
symptom
cerebellar
find
attack
frequenc
first
year
favor
prognost
factor
outlin
tabl
ii
unpredict
natur
diseas
firm
predict
individu
cours
determin
earli
diseas
predictor
extent
disabl
year
reliabl
patient
mild
earli
cours
may
later
develop
signific
disabl
death
result
relaps
extrem
rare
although
may
occur
complic
diseas
pneumonia
suicid
advanc
biotechnolog
signific
impact
treatment
ms
mani
year
treatment
reli
use
broadspectrum
immunosuppress
agent
numer
toxic
earli
trial
report
success
agent
withstand
larger
detail
investig
histor
diseas
difficult
studi
wide
variabl
present
clinic
cours
larg
number
patient
necessari
show
consist
reproduc
respons
drug
gold
standard
measur
diseas
activ
kurtzk
expand
disabl
scale
edss
scale
halfstep
gradient
measur
physic
disabl
unfortun
linear
scale
heavili
weight
toward
gait
especi
middl
rang
scale
newer
measur
disabl
includ
function
composit
evalu
gait
time
walk
upper
extrem
function
peg
test
cognit
function
pace
auditori
serial
addit
test
mri
use
surrog
marker
diseas
activ
genet
engin
led
manufactur
compound
interferonb
ifnb
produc
escherichia
coli
mammalian
ovarian
cell
gene
insert
copaxon
glatiram
acet
synthet
compound
made
four
amino
acid
agent
allow
select
immunomodul
thu
lower
toxic
conclus
evid
largescal
trial
agent
partial
effect
treatment
ms
betaseron
first
agent
assess
drug
shown
effect
decreas
risk
exacerb
ms
effect
slow
accumul
new
lesion
mri
although
drug
show
effect
slow
progress
diseas
measur
edss
effect
mri
led
mani
believ
longterm
outcom
patient
treat
better
expect
natur
histori
avonex
second
agent
approv
fda
drug
similar
effect
decreas
rate
relaps
primari
end
point
clinic
trial
efficaci
slow
disabl
measur
edss
drug
uniqu
featur
fda
approv
indic
copaxon
initi
investig
potenti
agent
induc
eae
convers
expect
anim
model
appear
protect
effect
led
addit
clinic
trial
copaxon
decreas
risk
relaps
favor
effect
mri
current
difficult
argu
one
agent
superior
other
treatment
relapsingremit
ms
fortun
allow
patient
option
worldwid
use
access
limit
high
cost
per
year
administr
intramuscular
subcutan
inject
nation
multipl
sclerosi
societi
issu
recommend
advoc
use
drug
earli
cours
diseas
base
increas
evid
earli
treatment
like
benefici
decreas
inflammatori
phase
diseas
prevent
axon
injuri
recent
trial
secondari
progress
ms
found
mix
result
use
betainterferon
mitoxantron
novantron
receiv
fda
approv
unit
state
treatment
secondari
progress
ms
immunosuppress
agent
shown
effect
european
studi
slow
progress
individu
secondari
progress
diseas
relapsingremit
diseas
unrespons
therapi
futur
clinic
trial
like
lack
placebo
group
uneth
leav
patient
untreat
partial
effect
therapi
avail
result
larger
lengthier
clinic
trial
necessari
show
effect
newer
agent
surrog
marker
diseas
activ
includ
mri
use
assess
util
drug
prior
larg
phase
trial
need
show
clinic
efficaci
understand
patholog
process
diseas
increas
possibl
differ
therapi
indic
differ
type
ms
exampl
individu
notabl
inflammatori
compon
determin
mri
tool
use
immunomodul
therapi
specif
effect
inflammatori
aspect
diseas
may
benefici
case
littl
inflammatori
diseas
appear
evid
growth
factor
mean
stimul
regenesi
cell
life
may
appropri
case
drug
shown
efficaci
ms
understand
pathophysiolog
ms
increas
thu
trial
consid
failur
final
caus
diseas
found
cure
like
fortun
advanc
understand
diseas
process
exponenti
recent
year
allow
hope
control
cure
diseas
near
futur
